Cargando…
Made from concentrate? A national web survey assessing dab use in the United States
BACKGROUND: Cannabis concentrates, including dabs, contain extremely high levels of Δ(9)-tetrahydrocannabinol (THC). Although these products appear to be gaining popularity among recreational cannabis consumers, little data exists regarding concentrate use in the US. We conducted a national web-base...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036911/ https://www.ncbi.nlm.nih.gov/pubmed/30029166 http://dx.doi.org/10.1016/j.drugalcdep.2018.05.022 |
_version_ | 1784693617913233408 |
---|---|
author | Sagar, Kelly A. Lambros, Ashley M. Dahlgren, Mary Kathryn Smith, Rosemary T. Gruber, Staci A. |
author_facet | Sagar, Kelly A. Lambros, Ashley M. Dahlgren, Mary Kathryn Smith, Rosemary T. Gruber, Staci A. |
author_sort | Sagar, Kelly A. |
collection | PubMed |
description | BACKGROUND: Cannabis concentrates, including dabs, contain extremely high levels of Δ(9)-tetrahydrocannabinol (THC). Although these products appear to be gaining popularity among recreational cannabis consumers, little data exists regarding concentrate use in the US. We conducted a national web-based survey to examine patterns of concentrate use, specifically dabbing. METHODS: 4077 respondents completed a survey designed to assess the use of conventional flower cannabis relative to dabs. Individuals provided information about frequency and magnitude of use, and also completed the Marijuana Motives Measure and Severity of Dependence Scale to examine whether dab users have different motives for use and/or demonstrate more severe consequences of use compared to those who only use conventional flower products. RESULTS: 58% of respondents reported they had tried dabs at least once and 36.5% endorsed regular use (once a month or more). Those who use regularly use dabs were significantly more likely to report using for experimentation (feeling “curious”) relative to reasons for using conventional flower products. Interestingly, motives reflecting positive effects (i.e., coping, sleep problems, relieving social anxiety) were endorsed more highly for flower use. In addition, regular dab users reported being more worried about their use of cannabis products relative to those who had tried dabs but did not use regularly. CONCLUSIONS: Results indicate that cannabis consumers do not necessarily choose dabs over flower products for positive effects, but rather appear to choose these highly potent products for experimentation. As concentrate use may lead to increased cannabis-related problems, studies directly assessing concentrate users are needed. |
format | Online Article Text |
id | pubmed-9036911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-90369112022-04-25 Made from concentrate? A national web survey assessing dab use in the United States Sagar, Kelly A. Lambros, Ashley M. Dahlgren, Mary Kathryn Smith, Rosemary T. Gruber, Staci A. Drug Alcohol Depend Article BACKGROUND: Cannabis concentrates, including dabs, contain extremely high levels of Δ(9)-tetrahydrocannabinol (THC). Although these products appear to be gaining popularity among recreational cannabis consumers, little data exists regarding concentrate use in the US. We conducted a national web-based survey to examine patterns of concentrate use, specifically dabbing. METHODS: 4077 respondents completed a survey designed to assess the use of conventional flower cannabis relative to dabs. Individuals provided information about frequency and magnitude of use, and also completed the Marijuana Motives Measure and Severity of Dependence Scale to examine whether dab users have different motives for use and/or demonstrate more severe consequences of use compared to those who only use conventional flower products. RESULTS: 58% of respondents reported they had tried dabs at least once and 36.5% endorsed regular use (once a month or more). Those who use regularly use dabs were significantly more likely to report using for experimentation (feeling “curious”) relative to reasons for using conventional flower products. Interestingly, motives reflecting positive effects (i.e., coping, sleep problems, relieving social anxiety) were endorsed more highly for flower use. In addition, regular dab users reported being more worried about their use of cannabis products relative to those who had tried dabs but did not use regularly. CONCLUSIONS: Results indicate that cannabis consumers do not necessarily choose dabs over flower products for positive effects, but rather appear to choose these highly potent products for experimentation. As concentrate use may lead to increased cannabis-related problems, studies directly assessing concentrate users are needed. 2018-09-01 2018-06-26 /pmc/articles/PMC9036911/ /pubmed/30029166 http://dx.doi.org/10.1016/j.drugalcdep.2018.05.022 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Sagar, Kelly A. Lambros, Ashley M. Dahlgren, Mary Kathryn Smith, Rosemary T. Gruber, Staci A. Made from concentrate? A national web survey assessing dab use in the United States |
title | Made from concentrate? A national web survey assessing dab use in the United States |
title_full | Made from concentrate? A national web survey assessing dab use in the United States |
title_fullStr | Made from concentrate? A national web survey assessing dab use in the United States |
title_full_unstemmed | Made from concentrate? A national web survey assessing dab use in the United States |
title_short | Made from concentrate? A national web survey assessing dab use in the United States |
title_sort | made from concentrate? a national web survey assessing dab use in the united states |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036911/ https://www.ncbi.nlm.nih.gov/pubmed/30029166 http://dx.doi.org/10.1016/j.drugalcdep.2018.05.022 |
work_keys_str_mv | AT sagarkellya madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates AT lambrosashleym madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates AT dahlgrenmarykathryn madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates AT smithrosemaryt madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates AT gruberstacia madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates |